ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Turnstone Biologics Corporation

Turnstone Biologics Corporation (TSBX)

0.6592
0.0192
(3.00%)
Closed 15 September 6:00AM
0.6592
0.00
(0.00%)
After Hours: 9:53AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.6592
Bid
0.66
Offer
0.73
Volume
73,140
0.6346 Day's Range 0.70
0.5699 52 Week Range 13.20
Market Cap
Previous Close
0.64
Open
0.6439
Last Trade
2
@
0.6401
Last Trade Time
Financial Volume
US$ 49,034
VWAP
0.670409
Average Volume (3m)
205,819
Shares Outstanding
23,128,454
Dividend Yield
-
PE Ratio
-0.28
Earnings Per Share (EPS)
-2.39
Revenue
19.31M
Net Profit
-55.2M

About Turnstone Biologics Corporation

Turnstone Biologics Corp. is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The Company is focused on developing tumor infiltrating lymphocytes (TIL) therapies designed to drive clinical benefit and curative outcomes across mu... Turnstone Biologics Corp. is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The Company is focused on developing tumor infiltrating lymphocytes (TIL) therapies designed to drive clinical benefit and curative outcomes across multiple solid tumors. Its selected TIL approach focuses on selecting and expanding potent tumor-reactive T cells to overcome the limitations of bulk TILs. Its pipeline includes TIDAL-01 and TIDAL-02. Its lead selected TIL product candidate, TIDAL-01, utilizes an unbiased identification and functional screening process to isolate and selectively expand the breadth of tumor-reactive TILs from the patient¿s tumor. Its next selected TIL program, TIDAL-02, is being designed to encompass a streamlined manufacturing process for tumor-reactive T cells and additional modifications to enhance TIL quality and function. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
La Jolla, California, USA
Founded
-
Turnstone Biologics Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TSBX. The last closing price for Turnstone Biologics was US$0.64. Over the last year, Turnstone Biologics shares have traded in a share price range of US$ 0.5699 to US$ 13.20.

Turnstone Biologics currently has 23,128,454 shares in issue. The market capitalisation of Turnstone Biologics is US$14.80 million. Turnstone Biologics has a price to earnings ratio (PE ratio) of -0.28.

TSBX Latest News

Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights

Announced positive initial data from Phase 1 trial of TIDAL-01 in metastatic colorectal cancer including a complete response in one of the four patients reported Cash position expected to fund...

Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer

Overall response rate (“ORR”) of 25% and 50% disease control rate ("DCR") observed in first four evaluable patients treated with TIDAL-01 with advanced CRC Complete response achieved in heavily...

Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights

SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.1808-21.52380952380.840.84620.56993057450.73490308CS
4-2.0008-75.21804511282.663.050.56992634381.16102101CS
12-2.2408-77.26896551722.93.87820.56992058191.91678981CS
26-4.7208-87.74721189595.386.0050.56991628302.35236853CS
52-10.7408-94.217543859611.413.20.56991514282.88099106CS
156-10.7408-94.217543859611.413.20.56991514282.88099106CS
2600000.7000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NOVVUNova Vision Acquisition Corporation
US$ 41.00
(207.35%)
17.4k
NOVVNova Vision Acquisition Corporation
US$ 37.0001
(200.08%)
202.75k
SMXSMX Security Matters Public Company
US$ 5.85
(138.78%)
49.72M
OMICSingular Genomics Systems Inc
US$ 12.38
(119.12%)
2.72M
TILInstill Bio Inc
US$ 84.75
(82.41%)
3.76M
GSIWGarden Stage Ltd
US$ 2.9693
(-75.66%)
4.21M
UPCUniverse Pharmaceuticals Inc
US$ 0.55
(-67.07%)
29.83M
VMARVision Marine Technologies Inc
US$ 0.77
(-48.67%)
30.61M
PRLDPrelude Therapeutics Inc
US$ 2.775
(-42.55%)
2.49M
CNEYCN Energy Group Inc
US$ 0.4335
(-37.17%)
4.79M
NVDANVIDIA Corporation
US$ 119.10
(-0.03%)
238.43M
XXII22nd Century Group Inc
US$ 0.3447
(28.00%)
183.73M
IMRXImmuneering Corporation
US$ 2.02
(41.26%)
136.36M
SQQQProShares UltraPro Short QQQ
US$ 8.17
(-1.33%)
127.78M
MULNMullen Automotive Inc
US$ 0.1328
(-20.48%)
120.81M

TSBX Discussion

View Posts
Stock Shakers Stock Shakers 3 weeks ago
https://www.tipranks.com/stocks/tsbx/forecast
👍️0
Monksdream Monksdream 4 weeks ago
TSBX new 52+week low
👍️0
jondoeuk jondoeuk 1 month ago
I assume (rightly or wrongly) it is down as they were supposed to have shared data on ~20-30 patients. There was also no conference call and they cut two indications (I agree with melanoma). Data shows promise, but you have to show the market more than that.

https://finance.yahoo.com/news/turnstone-biologics-corp-reports-positive-200100662.html
👍️0
Monksdream Monksdream 2 months ago
TSBX under $3
👍️0
Monksdream Monksdream 2 months ago
TSBX under $3
👍️0
stock1ace1 stock1ace1 3 months ago
$3.02
👍️0
stock1ace1 stock1ace1 3 months ago
$2.94 buys coming in
👍️0
stock1ace1 stock1ace1 3 months ago
Tsbx -> We remain on track and plan to provide a TIDAL-01 clinical update mid-year in connection with our next quarterly financial results.”
👍️0
stock1ace1 stock1ace1 3 months ago
$3.00s (200ma break) #Bullish
👍️0
stock1ace1 stock1ace1 3 months ago
Tsbx $2.99 Pending data look at chart -> https://schrts.co/JiDydKgr
👍️0
Monksdream Monksdream 4 months ago
TSBX under $3
👍️0
jondoeuk jondoeuk 4 months ago
CEO saying data in July-August.
👍️0
Monksdream Monksdream 5 months ago
TSBX under $3
👍️0
Laster Laster 5 months ago
Nice biotech company. Looks like it wants to break out past $3.50.
I think it has a lot more to run,
JMO.
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
TSBX....here we go...monster bio
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
TSBX...MONSTER BIO BEAST IS READY TO BLOW UP
👍️0
jondoeuk jondoeuk 7 months ago
What was?
👍️0
Awl416 Awl416 10 months ago
That was quick
👍️0
jondoeuk jondoeuk 11 months ago
New #JITC article: Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients https://t.co/jORw8004JP @JohnEMullinaxMD pic.twitter.com/a7RR2K5MrQ— Journal for ImmunoTherapy of Cancer (@jitcancer) October 6, 2023
👍️0
jondoeuk jondoeuk 12 months ago
Upcoming https://finance.yahoo.com/news/turnstone-biologics-present-preclinical-data-100000133.html
👍️0

Your Recent History

Delayed Upgrade Clock